| 70.31 Data as of May 24 |  -0.77 / -1.08%Today’s Change | 37.77 Today|||52-Week Range 77.11 | +26.48% Year-to-Date |
| QIAGEN Downgraded to Strong Sell - Analyst Blog May 21 / Zacks.com | Much Awaited Test Launch by Genomic - Analyst Blog May 15 / Zacks.com |
| Illumina Inc. (ILMN): Today's Featured Health Care Winner May 20 / TheStreet.com | Myriad Soars Higher on Celeb Clout - Analyst Blog May 15 / Zacks.com |
| Previous close | 71.08 |
| Today’s open | 70.39 |
| Day’s range | 69.81 - 70.78 |
| Volume | 1,111,968 |
| Average volume (3 months) | 1,378,939 |
| Market cap | $8.7B |
| Dividend yield | -- |
| Earnings growth (last year) | +82.26% |
| Earnings growth (this year) | +5.70% |
| Earnings growth (next 5 years) | +16.11% |
| Revenue growth (last year) | +8.81% |
| P/E ratio | 93.7 |
| Price/Sales | 5.86 |
| Price/Book | 6.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| WATWaters Corp | +0.62 | +0.64% |
| MTDMettler-Toledo Inter... | -0.09 | -0.04% |
| QGENQiagen NV | +0.05 | +0.26% |
| PKIPerkinElmer Inc | -0.03 | -0.09% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.40 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $151.3M |
| Net profit margin | 13.17% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jay T. Flatley |
Senior Vice President- Operations William Bonnar, MBA |
Corporate headquarters San Diego, California |
.
